πŸ‡ΊπŸ‡Έ FDA
Patent

US 11466024

Bicylic compound acting as an inhibitor

granted A61PA61P17/06A61P37/00

Quick answer

US patent 11466024 (Bicylic compound acting as an inhibitor) held by Medshine Discovery Inc. expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P17/06, A61P37/00